In a study among young adult cancer survivors published in the JCO Oncology Practice, co-corresponding authors, Joel Milam, PhD, professor of epidemiology and biostatistics in UCI’s Program in Public Health and Alexandre Chan, PharmD, founding chair of clinical pharmacy practice for the UCI School of Pharmacy & Pharmaceutical Sciences, uncovered connections between CRCI and reports of vaping, which can influence long-term clinical care and outcomes. 

Using a CRCI survey, Ding Quan (“Quinton”) Ng, first author of this study and a UCI doctoral student in Chan’s research lab, validated the relationship between CRCI, vaping and overall poorer outcomes.

Find the full article here.